Ftse Mib
33.197,12
-0,09%
DAX
19.065,60
0,34%
S&P 500
5.902,30
-0,25%
NASDAQ
18.726,53
-1,26%
Bitcoin
96.135,78
1,88%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ T2 Biosystems Inc (TTOO) T2 Biosystems Inc (TTOO) Notizie

T2 Biosystems Inc

TTOO
0,45
-0,0118 (-2,56%)
Ultimo aggiornamento: 16:26:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202422:45EDGAR2Form ARS - Annual Report to Security Holders
20/11/202422:30EDGAR2Form DEF 14A - Other definitive proxy statements
15/11/202415:54EDGAR2Form 8-K - Current report
14/11/202422:05GLOBET2 Biosystems Announces Third Quarter 2024 Financial Results
14/11/202421:49EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202421:38EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
08/11/202423:00EDGAR2Form PRE 14A - Other preliminary proxy statements
08/11/202415:30EDGAR2Form 8-K - Current report
07/11/202403:02EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
05/11/202414:00GLOBET2 Biosystems to Report Third Quarter 2024 Financial Results..
16/10/202422:59EDGAR2Form 8-K - Current report
08/10/202422:05GLOBET2 Biosystems to Host Business Update Call on October 10,..
08/10/202415:00GLOBET2 Biosystems, Inc. and Prxcision, Inc. Announce..
07/10/202415:05GLOBET2 Biosystems Announces Exclusive U.S. Agreement with..
07/10/202415:00EDGAR2Form 8-K - Current report
07/10/202415:00GLOBET2 Biosystems Announces Preliminary Third Quarter 2024..
23/9/202415:00GLOBET2 Biosystems Highlights New Article Published in The..
20/9/202415:00GLOBET2 Biosystems Achieves Successful Defense of Patent for..
20/9/202414:59EDGAR2Form 8-K - Current report
16/9/202415:16EDGAR2Form 8-K - Current report
16/9/202415:00GLOBET2 Biosystems Receives FDA Clearance to Market the T2Candida..
09/9/202415:10EDGAR2Form 8-K - Current report
09/9/202415:00GLOBET2 Biosystems Provides Updates on its New Product..
27/8/202422:05GLOBET2 Biosystems to Participate in the H.C. Wainwright 26th..
23/8/202422:31EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/8/202422:49EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:05GLOBET2 Biosystems to Attend Upcoming Investor Conferences
29/7/202423:00EDGAR2Form 8-K - Current report
29/7/202422:05GLOBET2 Biosystems Announces Second Quarter 2024 Financial..
29/7/202422:02GLOBET2 Biosystems Announces Commercial Expansion Through..
22/7/202422:05GLOBET2 Biosystems to Report Second Quarter 2024 Financial..
19/7/202423:04EDGAR2Form S-3 - Registration statement under Securities Act of..
19/7/202422:16EDGAR2Form 8-K - Current report
25/6/202415:00GLOBET2 Biosystems Announces Commercial Expansion Through Hong..
25/5/202403:04EDGAR2Form S-3 - Registration statement under Securities Act of..
22/5/202422:49EDGAR2Form 8-K - Current report
22/5/202415:00GLOBET2 Biosystems Regains Compliance with Nasdaq Continued..
20/5/202413:00EDGAR2Form 8-K - Current report
17/5/202422:05GLOBET2 Biosystems Announces Closing of $8 Million Private..
15/5/202413:00GLOBET2 Biosystems Announces $8 Million Private Placement Priced..
14/5/202423:00GLOBET2 Biosystems Announces CRG’s Conversion from Preferred..
14/5/202422:55EDGAR2Form RW - Registration Withdrawal Request
14/5/202422:43EDGAR2Form 8-K - Current report
14/5/202401:21EDGAR2Form SC 13D/A - General statement of acquisition of..
14/5/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202401:46EDGAR2Form SC 13D/A - General statement of acquisition of..
07/5/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:48EDGAR2Form 8-K - Current report
07/5/202415:00GLOBET2 Biosystems Announces Letter of Intent to Enter Strategic..
06/5/202423:27EDGAR2Form S-1/A - General form for registration of securities..
Apertura: 0,455 Min: 0,4156 Max: 0,4796
Chiusura: 0,4618

La tua Cronologia

NASDAQ
TTOO
T2 Biosystems
NASDAQ
AROW
Arrow Financial
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network